Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma
Year: 2025
Type: article
Abstract: Inflammation is a widely recognized key contributor to KRAS-driven lung adenocarcinoma (LUAD). Tumor-associated macrophages (TAM) are an integral part of the tumor microenvironment and create a supportive niche that sustains inflammation-driven tumorigenesis. In the present study, we unravel a dual role of sphingosine kinase 1 (SPHK1) in KRAS-driven LUAD. While SPHK1 promotes tumorigenesis in in vitro experimental models, it paradoxically suppresses tumorigenesis in in vivo models of KRAS-mutated LUAD. Mechanistically, tumor-intrinsic loss of SPHK1 leads to disrupted lipid homeostasis, increased inflammation and infiltration by TAM, ultimately driving tumor progression. Thus, our study suggests that clinically targeting the SPHK1/S1P axis could potentially result in increased tumor progression, possibly by rewiring the tumor microenvironment toward a more inflammatory and pro-tumorigenic state.
Source: Cancer Letters
Authors: Andreea C. Luca, Margarita Kurnaeva, Daniel K. John, Michael Machtinger, Nadja H.J. Vollmer, Bernadette Mödl, J. Thomas Hannich, Margret Eckhard, Hon S. Lam, Laszlo Musiejovsky, Christoph Trenk, Monika Homolya, Clemens Fürnsinn, Andy Sombke, Gernot Schabbauer, Robert Eferl, Omar Sharif, Emilio Casanova, Herwig P. Moll
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,960
OpenAlex ID: W4409563485
